🇺🇸 FDA
Patent

US 11180517

Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

granted A61KA61K47/36A61K47/38

Quick answer

US patent 11180517 (Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use) held by Compass Pathfinder Limited expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Compass Pathfinder Limited
Grant date
Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K47/36, A61K47/38, A61K9/0053, A61K9/2054